ESC 2020: Effects of GLP1 RAs, SGLT2is and Their Combination on Vascular Function and Myocardial Work Index in Patients with T2DM — Dr John Thymis

 

Dr John Thymis (Attikon University Hospital, Athens, GR) presents the results of his trial that investigated the effects of GLP1 receptor agonists and SGLT2 inhibitors and their combination on vascular function and MWI in patients with type 2 diabetes. 

Recorded remotely from Athens, 2020. 

This presentation was supported by an unrestricted educational grant from Novo Nordisk.